Journal Title：Cancer Nanotechnology

Aim:

Recognizing cancer as a group of diseases caused by nanostructural problems (i.e. with DNA) and also that there are unique benefits to approaches inherently involving nanoscale structures and processes to treat the disease, the journal Cancer Nanotechnology aims to disseminate cutting edge research; to promote emerging trends in the use of nanostructures and the induction of nanoscale processes for the prevention, diagnosis, treatment of cancer; and to cover related ancillary areas.

Scope:

Articles describing original research in the use of nanostructures and the induction of nanoscale processes for the prevention, diagnosis and treatment of cancer (open submission process). Review, editorial and tutorial articles picking up on subthemes of emerging importance where nanostructures and the induction of nanoscale processes are used for the prevention, diagnosis and treatment of cancer.

目的：

認(rèn)識(shí)到癌癥是一組由納米結(jié)構(gòu)問(wèn)題（即 DNA）引起的疾病，并且認(rèn)識(shí)到涉及納米級(jí)結(jié)構(gòu)和過(guò)程的治療方法具有獨(dú)特的優(yōu)勢(shì)，因此《癌癥納米技術(shù)》雜志旨在傳播前沿研究；促進(jìn)使用納米結(jié)構(gòu)和誘導(dǎo)納米級(jí)過(guò)程預(yù)防、診斷和治療癌癥的新興趨勢(shì)；并涵蓋相關(guān)輔助領(lǐng)域。

范圍：

描述使用納米結(jié)構(gòu)和誘導(dǎo)納米級(jí)過(guò)程預(yù)防、診斷和治療癌癥的原創(chuàng)研究的文章（開放提交流程）。評(píng)論、編輯和教程文章，重點(diǎn)介紹新興重要子主題，其中納米結(jié)構(gòu)和誘導(dǎo)納米級(jí)過(guò)程用于預(yù)防、診斷和治療癌癥。

Cancer Nanotechnology創(chuàng)刊于2010年，由Springer Vienna出版商出版，收稿方向涵蓋Pharmacology, Toxicology and Pharmaceutics - Pharmaceutical Science全領(lǐng)域，此刊是該細(xì)分領(lǐng)域中屬于非常不錯(cuò)的SCI期刊，在行業(yè)細(xì)分領(lǐng)域中學(xué)術(shù)影響力較大，專業(yè)度認(rèn)可很高，所以對(duì)原創(chuàng)文章要求創(chuàng)新性較高，如果您的文章質(zhì)量很高，可以嘗試。平均審稿速度 15 Weeks ，影響因子指數(shù)4.5，該期刊近期沒(méi)有被列入國(guó)際期刊預(yù)警名單，廣大學(xué)者值得一試。